Cargando…

Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation

Detalles Bibliográficos
Autor principal:	Phanish, M. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795441/ https://www.ncbi.nlm.nih.gov/pubmed/27051130 http://dx.doi.org/10.4103/0971-4065.167275

Ejemplares similares

Chronic active antibody mediated rejection associated with human leukocyte antigen-C*07 antibodies
por: Dorwal, P., et al.
Publicado: (2016)

Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation
por: Zhang, Xiaohai, et al.
Publicado: (2017)

Human leukocyte antigen antibody incompatible renal transplantation
por: Krishnan, N. S., et al.
Publicado: (2012)

Steroid Avoidance in Low-Immunologic Risk Kidney Transplant Recipients: The New Normal?
por: Legendre, Christophe
Publicado: (2021)

Yoga, rheumatoid arthritis & human leukocyte antigen-G
por: Mittal, Balraj
Publicado: (2022)

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020)

Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies
por: Alelign, Tilahun, et al.
Publicado: (2018)

Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Assessment of Anti-Human Leukocyte Antigen (HLA)-Antibody-Dependent Humoral Response in Patients before and after Lung Transplantation
por: Stanjek-Cichoracka, Anita, et al.
Publicado: (2022)

Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation
por: Liu, Wei, et al.
Publicado: (2021)

Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population
por: Kwofie, Luyanda, et al.
Publicado: (2021)

Assessment of human leukocyte antigen matching algorithm PIRCHE‐II on liver transplantation outcomes
por: Kok, Gautam, et al.
Publicado: (2022)

Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide
por: Kanakry, Christopher G., et al.
Publicado: (2017)

Long-term mycophenolate monotherapy in human leukocyte antigen (HLA)-identical living-donor kidney transplantation
por: Gascó, Blanca, et al.
Publicado: (2014)

Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation
por: Peng, Bo, et al.
Publicado: (2019)

Successful treatment of early acute antibody-mediated rejection in an human leukocyte antigen-incompatible and ABO-incompatible living-donor kidney transplant patient
por: Gang, Sujin, et al.
Publicado: (2019)

It Is Time to Consider Human Leukocyte Antigen Compatibility in Lung Transplantation
por: Rhee, Chin Kook
Publicado: (2022)

HLA antibody testing: a tool to facilitate not to prevent organ transplantation
por: Claas, Frans H J
Publicado: (2008)

Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation
por: Gu, Yue, et al.
Publicado: (2020)

Immunological Risk Factors in Paediatric Kidney Transplantation
por: Friedersdorff, Frank, et al.
Publicado: (2021)

Risk assessment of substance use disorders based on the human leukocyte antigen (HLA)
por: James, Lisa M., et al.
Publicado: (2023)

Commentary: Understanding immunological tests for uveitis – ten essentials
por: Patel, Anamika, et al.
Publicado: (2020)

Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients
por: Jahnukainen, Timo, et al.
Publicado: (2019)

Impact of high body mass index on allograft outcomes in kidney transplant recipients with presensitization to human leukocyte antigen
por: Park, Yohan, et al.
Publicado: (2021)

Human Leukocyte Antigen‐Based Risk Stratification in Heart Transplant Recipients—Implications for Targeted Surveillance
por: Nilsson, Johan, et al.
Publicado: (2019)

Human Leukocyte Antigen Alleles and Cytomegalovirus Infection After Renal Transplantation
por: Futohi, Farzaneh, et al.
Publicado: (2015)

Sheepish B cells: evidence for antigen-independent antibody diversification in humans and mice
por: Tarlinton, David
Publicado: (2008)

A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
por: Legendre, Christophe
Publicado: (2019)

Leukocyte Telomere Length and Cancer Risk: A Dynamic Problem
por: Gu, Jian
Publicado: (2015)

WCN23-0022 SUCCESSFUL KIDNEY TRANSPLANTATION FROM COVID-19 POSITIVE DONORS
por: GAMA, R., et al.
Publicado: (2023)

Efficacy of Combined Desensitization Therapy Based on Protein A Immunoadsorption on Anti-human Leukocyte Antigen Antibodies in Sensitized Kidney Transplant Recipients: A Retrospective Study
por: Chen, XiaoFei, et al.
Publicado: (2022)

ABO-incompatible renal transplantation in developing world – crossing the immunological (and mental) barrier
por: Jha, P. K., et al.
Publicado: (2016)

COVID-19 infection in kidney transplant recipients
por: Banerjee, Debasish, et al.
Publicado: (2020)

Patients on the Transplant Waiting List Have Anti-Swine Leukocyte Antigen Class I Antibodies
por: Wang, Zheng-Yu, et al.
Publicado: (2023)

Biochemical and immunological characterizations of antigens recognised by human monoclonal antibodies.
por: Imam, A., et al.
Publicado: (1989)

Male human papillomavirus infection post-kidney transplant: an overlooked disease
por: Genzer, Oksana, et al.
Publicado: (2012)

Epstein-Barr Virus Nuclear Antigen 1: from Immunologically Invisible to a Promising T Cell Target
por: Münz, Christian
Publicado: (2004)

Mapping the Human Leukocyte Antigen Diversity among Croatian Regions: Implication in Transplantation
por: Grubic, Zorana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8o7dee3dck1imou1j5p4v9hk5a